{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-035562","form_type":"8-K","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2025-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.422349+00:00","generated_at":"2026-05-25T03:25:59.833112+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Precision BioSciences reshuffles director classes, cuts board to six members","bullets":["Board reclassified Michael Amoroso from Class I to Class II director.","Melinda Brown reclassified from Class III to Class I director.","Board size reduced from seven to six directors effective March 4, 2025.","Changes follow prior resignation of Sam Wadsworth from the Board.","No disagreements cited; committee assignments unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-035562","json":"https://secwatch.observer/filing/0000950170-25-035562.json","markdown":"https://secwatch.observer/filing/0000950170-25-035562.md","text":"https://secwatch.observer/filing/0000950170-25-035562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025035562/0000950170-25-035562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000095017025035562/dtil-20250304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T03:25:59.833112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}